Granulomatosis with polyangiitis risk factors

Jump to navigation Jump to search

Granulomatosis with polyangiitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Granulomatosis with polyangiitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Granulomatosis with polyangiitis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Granulomatosis with polyangiitis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Granulomatosis with polyangiitis risk factors

CDC on Granulomatosis with polyangiitis risk factors

Granulomatosis with polyangiitis risk factors in the news

Blogs on Granulomatosis with polyangiitis risk factors

Directions to Hospitals Treating Granulomatosis with polyangiitis

Risk calculators and risk factors for Granulomatosis with polyangiitis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Amandeep Singh M.D.[3]

Overview

Common risk factors in the development of granulomatosis with polyangitis(GPA) are age group of 40-65 years and presence of variant HLA-DPB1*0401 with ANCA.

Risk Factors

Common Risk Factors

  • Common risk factors in the development of granulomatosis with polyangitis(GPA) include:
    • Age= 40-65 years
    • Genetic= HLA DPB1[1]
      • Variant  HLA-DPB1*0401 in those associated with ANCA [2][3]
    • Infection leading to granulomas[4]

Less Common Risk Factors

  • Less common risk factors in the development of granulomatosis with polyangitis(GPA) include:
    • Exposure to silica[5]

References

  1. Wieczorek S, Holle JU, Epplen JT (January 2010). "Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome". Curr Opin Rheumatol. 22 (1): 8–14. doi:10.1097/BOR.0b013e3283331151. PMID 19864953.
  2. https://ghr.nlm.nih.gov/condition/granulomatosis-with-polyangiitis#sourcesforpage
  3. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT (April 2004). "New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes". Hum. Genet. 114 (5): 468–77. doi:10.1007/s00439-004-1092-z. PMID 14968360.
  4. Spagnolo P, Richeldi L, du Bois RM (December 2008). "Environmental triggers and susceptibility factors in idiopathic granulomatous diseases". Semin Respir Crit Care Med. 29 (6): 610–9. doi:10.1055/s-0028-1101271. PMID 19221959.
  5. Hogan SL, Cooper GS, Savitz DA, Nylander-French LA, Parks CG, Chin H, Jennette CE, Lionaki S, Jennette JC, Falk RJ (March 2007). "Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study". Clin J Am Soc Nephrol. 2 (2): 290–9. doi:10.2215/CJN.03501006. PMC 4049534. PMID 17699427.